Optimizing Atopic Dermatitis Outcomes: Nordic Expert Panel Insights on Emollient Selection and Treatment Concordance
Check out this groundbreaking publication featured in the Journal of Drugs in Dermatology. Managing chronic atopic dermatitis requires an ongoing, multi-faceted approach aimed at restoring skin barrier function, alleviating persistent symptoms, and reducing flare frequency. While topical therapy remains the foundational pillar of disease management, clinicians frequently encounter therapeutic resistance driven by patient non-adherence and suboptimal product performance.
To address these persistent practice challenges, the Nordic European Countries Atopic Dermatitis expert panel conducted a thorough evaluation of survey data, published literature, and clinical practice insights. The panel focused on synthesizing current skincare recommendations while evaluating specific interventions designed to enhance long-term treatment alignment and patient engagement.
The panel established five consensus statements emphasizing that emollient therapy serves as the essential baseline for effective disease control. Crucially, the review highlights that advanced, multi-ingredient emollient formulations demonstrate superior clinical efficacy and user satisfaction compared to traditional, basic emollients. To overcome non-adherence, the experts recommend integrating structured tools into routine care, including evidence-based patient education models, individualized action plans, and expanded follow-up protocols through physical or digital channels.
Selecting the right emollient regimen and fostering patient trust are critical factors in achieving sustained remission. Read the full consensus paper in the JDD to explore the complete panel recommendations, practical educational strategies, and actionable tools to enhance treatment adherence in your daily dermatology practice.
Blog write-up assisted by AI
